Conscience VC

Conscience VC Research Investment Thesis Conscience VC is an early-stage venture capital fund founded in 2020 by chemical engineer Ariana Thacker, pioneering the intersection of consumer-facing science and defensible technology. The fund invests in science-led consumer companies that use a rigorous "12+ months to replicate" defensibility test—meaning the technology must be genuinely difficult to copy and replicate within a reasonable timeframe. This thesis reflects a disciplined approach to identifying companies with true technological moats rather than pure consumer trends. Ariana brings a technical founder's perspective to venture capital, having deep expertise in chemical engineering and a demonstrated commitment to diversity and inclusion in tech. The fund is explicitly mission-driven, targeting companies that solve real consumer problems using rigorous science while generating positive impact for underrepresented founders. Approximately 80% of the portfolio is led by underrepresented founders, making diversity a core investment criterion, not an afterthought. Sector and Market Focus Conscience VC focuses on three primary consumer-facing science sectors: Health & Wellness (Primary): Digital health and personalized medicine Genomics and biotech consumer applications Mental and physical health optimization Mold-related health and environmental science (evident from MoldCo investment) Preventive care technologies Women's health and longevity Climate & Sustainability (Secondary): Consumer-facing climate solutions Environmental remediation technology Sustainable consumer products backed by science Innovation & Science-Based Consumer Tech (Tertiary): AI agents for consumer and small business automation (Multiagents investment) Digital tools that democratize complex science Science-enabled consumer platforms The fund is notably selective, avoiding pure consumer apps, entertainment, or social media plays without scientific defensibility. They explicitly seek companies where the science creates a sustainable competitive advantage. Investment Stage and Ticket Size Conscience VC is a Pre-Seed to Seed stage investor with focus on very early-stage companies: Stage Distribution: Pre-Seed: Primary focus ("no time too early" for right founders) Seed: Secondary focus Occasional follow-ons in existing portfolio Check Size: Pre-Seed: $100K-$500K typical range Seed: $250K-$3M typical range Notable: Invested $3M in MoldCo pre-seed (December 2024), indicating ability to write larger checks for conviction bets Recent seed: $0.28M in Multiagents (December 2025) The fund raised Conscience VC I with $10M closed in July 2022, currently in active deployment. Recent Investment Activity & Portfolio Conscience VC has made 10 confirmed investments as of December 2025, with recent activity showing active deployment: Recent Investments (Last 12 months): December 3, 2025: Multiagents (Seed, $0.28M) - AI agents for business automation December 10, 2024: MoldCo (Pre-Seed, $3M) - Digital health platform for mold detection and prevention (co-led with Behind Genius Ventures, Bleu Capital, Boost VC, Moth Fund, Night Ventures, SALT Fund, Starship Ventures) October 2024: Unnamed seed investment March 2024: Unnamed pre-seed investment Known Portfolio Companies: MoldCo - Clinician-led digital health platform for mold toxicity detection and prevention (health/science) Multiagents - AI agents platform for enterprise task automation Humane Genomics - Personalized cancer therapies using synthetic virus engineering (biotech/health) Junction (mentioned as portfolio company, named in Digital Health 100 for 2026) Portfolio Characteristics: Mix of B2B SaaS/tools and healthcare/biotech Strong emphasis on underrepresented founders Companies solving real, measurable problems with scientific rigor Fund status: Actively deploying from Fund I Team & Investment Approach Leadership: Ariana Thacker: Founding Partner and Solo GP. Chemical engineer by training, former angel investor with 30+ company portfolio experience. Known for: Deep technical diligence capability Exceptional founder support and mentorship Creating in-house resources for portfolio companies (Conscience Founder programs, apprenticeships) Strong network across science, healthcare, and entrepreneurship communities Public speaker and thought leader on solo GPs, diversity in VC, and science-backed investing Supporting Team: Approximately 30 team members (per CB Insights), suggesting meaningful operational support despite solo GP structure Demonstrated commitment to founder education and development programs Decision Process & Investor Style Ariana's approach emphasizes: Technical diligence : Deep evaluation of the science and defensibility claims Founder-first mentorship : Creating resources, making introductions, providing strategic guidance Long-term partnership : Described by founders as "founder obsessed," making meaningful connections, and highly available Diversity integration : Actively investing in underrepresented founders as core thesis, not diversity check-box Pattern recognition : Ability to synthesize information across verticals and zoom between macro and micro perspectives Decision timeline appears to be moderate (weeks to months for promising founders), with emphasis on quality of founder and rigor of science over speed. Geographic & Network Focus Primary Markets: Miami, Florida (headquarters since 2024) US-based (reflected in portfolio) Selective international interests (recent Brazil investment in Multiagents) Network: Active in Silicon Valley venture circles Strong connections in biotech/healthcare ecosystem Women in tech and underrepresented founder networks Science and academic partnerships Lead Tendency & Co-Investment Patterns Conscience VC demonstrates strong lead tendency , particularly in pre-seed rounds: Leads or co-leads most investments MoldCo pre-seed shows syndication with Behind Genius Ventures and 6 other quality VCs Comfortable being first check or lead investor for strong founder+science combinations Strategic co-investor selection suggesting attention to round composition Notable Recognition & Market Position Featured in "Business Insider" article on solo capitalists reshaping VC (2021) Covered in "The Generalist" on solo GP investing Fund highlighted in multiple VC publications as innovation in capital structure Ariana recognized as "Emerging 50" investor (Signature Block) Portfolio companies featured in prestigious lists (Digital Health 100) Active podcast and media presence (Sure Shot, Carta, Stonks, The Consumer VC, Behind Genius Ventures, etc.) Fund Status & Deployment Runway Fund I Size : $10M (closed July 2022) Current Status : Actively deploying (4+ investments in last 12 months despite small fund size) Pace : Conservative deployment suggesting extended fund life (3-4+ years remaining) Follow-on Capacity : Demonstrated via portfolio follow-ons and reserves Fund II : No public announcement as of February 2026, but given market conditions and successful first fund, likely being raised or planned Investment Philosophy & Founder Criteria Conscience VC seeks: Technical founders with deep domain expertise in their science area Mission-aligned founders, especially from underrepresented backgrounds Scientists turned entrepreneurs (similar to Ariana's journey) Founders with clear understanding of their competitive moat and defensibility Teams willing to invest time in rigorous scientific validation Commitment to impact beyond pure financial returns Anti-Thesis & What They Don't Fund Pure consumer social/apps without scientific defensibility Business models relying on trends rather than technology Teams lacking technical rigor or scientific validation Founders primarily motivated by quick exits Non-inclusive team compositions Recent Founder Experience & Testimonials From founder recommendations on Ariana's LinkedIn: "Brilliant critical thinker with rare cross-vertical understanding" "Synthesizes information quickly and thoroughly, provides support at the right time" "Amazing sense of what makes sense in the marketplace" "Consummately available and founder obsessed" "Makes incredible intros with her vast network" Founders highlight her rare combination of technical capability, market intuition, and operational support Market Context & Positioning Conscience VC operates in a unique market position: Not a traditional climate/impact fund (though invests in climate companies) Not a life sciences/biotech fund (though heavily invests in health/biotech) Not a consumer fund (though invests in consumer applications) Rather: A science-first fund that happens to work at consumer and B2B intersection This positioning makes them selective but highly attractive to founders with scientifically defensible solutions to real consumer problems. The "12+ months to replicate" test creates genuine competition for fundable companies. Fund Strengths & Unique Positioning Technical founder as GP - Deep diligence capability most VCs lack Solo GP model - Faster decisions, clear accountability, founder-direct relationship Small fund focused on impact - Aligned incentives with founder success, not just returns Diversity-integrated thesis - Not performative, but core to how capital is deployed Operator-level support - In-house programs, resources, real mentorship (not just intros) Clear investment thesis - Founders know exactly what to expect 2026 Outlook Based on available data: Continuing to deploy Fund I with likely 2-3 more investments this year Likely raising Fund II given successful Fund I performance and market recovery Expanding portfolio support infrastructure based on recent team growth Maintaining selective approach despite market pressure (only 10 investments from $10M fund over 4 years) Increasing focus on solving real health/science problems in emerging categories (mold health, AI for automation, etc.)